Red Paper
International Journal of Pharmaceutical Sciences and Drug Analysis
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9246, E-ISSN: 2788-9254
Printed Journal   |   Refereed Journal   |   Peer Reviewed Journal
Peer Reviewed Journal

2025, Vol. 5, Issue 2, Part B

Understanding anencephaly: A rare congenital disorder


Author(s): Anita G Choudhary, Reena J Choudhary, Akshata S Patil and Tushar T Shelke

Abstract:

A significant amount of the brain, skull, and scalp are absent in anencephaly, a severe congenital neural tube defect (NTD). It arises when the anterior neural tube fails to close during the development of the embryo, usually during the first 23 to 26 days of pregnancy. Affected fetuses frequently die soon after birth or are stillborn, making the syndrome consistently deadly. Maternal folate deficiency, poorly managed diabetes, exposure to specific drugs or chemicals, and a family history of NTDs are among the environmental and genetic risk factors linked to anencephaly. Ultrasonography is frequently used to make the diagnosis during pregnancy, and high maternal serum alpha-fetoprotein (AFP) values are used to confirm it Anencephaly has no known cure or effective therapy, despite advancements in prenatal care. Its incidence has been greatly decreased by preventative measures, including taking enough folic acid supplements before getting pregnant and during the first trimester of pregnancy.



DOI: 10.22271/27889246.2025.v5.i2b.137

Pages: 108-112 | Views: 117 | Downloads: 47

Download Full Article: Click Here

International Journal of Pharmaceutical Sciences and Drug Analysis
How to cite this article:
Anita G Choudhary, Reena J Choudhary, Akshata S Patil, Tushar T Shelke. Understanding anencephaly: A rare congenital disorder. Int J Pharm Sci Drug Anal 2025;5(2):108-112. DOI: 10.22271/27889246.2025.v5.i2b.137
International Journal of Pharmaceutical Sciences and Drug Analysis
Call for book chapter